These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19175875)

  • 1. Changes of non-invasive markers and FibroScan values during HCV treatment.
    Vergniol J; Foucher J; Castéra L; Bernard PH; Tournan R; Terrebonne E; Chanteloup E; Merrouche W; Couzigou P; de Lédinghen V
    J Viral Hepat; 2009 Feb; 16(2):132-40. PubMed ID: 19175875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.
    Halfon P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Cacoub P
    Antivir Ther; 2009; 14(2):211-9. PubMed ID: 19430096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir.
    Bernuth S; Yagmur E; Schuppan D; Sprinzl MF; Zimmermann A; Schad A; Kittner JM; Weyer V; Knapstein J; Schattenberg JM; Wörns MA; Galle PR; Zimmermann T
    Dig Liver Dis; 2016 Mar; 48(3):291-7. PubMed ID: 26514736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
    de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.
    Dolmazashvili E; Zhamutashvili M; Svanidze M; Nizharadze N; Abutidze A
    Georgian Med News; 2008 Dec; (165):83-7. PubMed ID: 19124923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan.
    Wang JH; Changchien CS; Hung CH; Tung WC; Kee KM; Chen CH; Hu TH; Lee CM; Lu SN
    J Gastroenterol Hepatol; 2010 May; 25(5):964-9. PubMed ID: 20546451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
    Lepida A; Colombo M; Fernandez I; Abdurakhmanov D; Ferreira PA; Strasser SI; Urbanek P; Mangia A; Calleja JL; Iraqi W; DeMasi R; Lonjon-Domanec I; Moreno C; Wedemeyer H
    PLoS One; 2015; 10(9):e0138503. PubMed ID: 26398503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
    Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
    Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2007 Nov; 79(11):1686-95. PubMed ID: 17854035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C.
    Crisan D; Radu C; Grigorescu MD; Lupsor M; Feier D; Grigorescu M
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):375-82. PubMed ID: 23256120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.
    Gheorghe L; Iacob S; Grigorescu M; Sporea I; Sirli R; Damian D; Gheorghe C; Iacob R
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):51-6. PubMed ID: 19337634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
    Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
    Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient elastography (FibroScan).
    de Lédinghen V; Vergniol J
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):58-67. PubMed ID: 18973847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.
    ANRS CO13 HEPAVIH Cohort
    AIDS; 2015 Sep; 29(14):1821-30. PubMed ID: 26372388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
    Carrión JA; Navasa M; García-Retortillo M; García-Pagan JC; Crespo G; Bruguera M; Bosch J; Forns X
    Gastroenterology; 2007 May; 132(5):1746-56. PubMed ID: 17484872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.